Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

23 Jul 2013 11:20

UNICORN AIM VCT PLC - Interim Management Statement

UNICORN AIM VCT PLC - Interim Management Statement

PR Newswire

London, July 23

Unicorn AIM VCT plc Interim Management Statement For the period from 1 April 2013 to 30 June 2013 Introduction The Company has prepared this Interim Management Statement (IMS) in accordancewith the Disclosure and Transparency Rules of the UK Listing Authority. The IMScovers the three month period ended 30 June 2013, together with relevantinformation up to the date of publication. Investment Objective The objective of the Company is to provide Shareholders with an attractivereturn from a diversified portfolio of investments, predominantly in the sharesof AIM quoted companies, by maximising the stream of dividend distributions toShareholders from the income and capital gains generated by the portfolio. It is also the objective that the Company should continue to qualify as aVenture Capital Trust, so that Shareholders benefit from the taxationadvantages that this brings. To achieve this at least 70% of the Company'stotal assets are to be invested in qualifying investments of which 30% by valuemust be in ordinary shares carrying no preferential rights to dividends orreturn of capital and no rights to redemption. Performance The three month period to 30 June 2013 was relatively volatile for equitymarkets, with UK indices rising strongly in May only to fall back sharplyduring June. Over the period as a whole, on a total return basis, the FTSEAll-Share Index (excluding investment trusts) fell by 1.7%, the FTSE AIMAll-Share Index was down by 5.2%, whilst the Numis Smaller Companies Indexgained by 0.8%. The Company delivered strong outperformance during the period with Net AssetValue (NAV) increasing by 3.4%. NAV performance is calculated on a total returnbasis, after adding back dividends paid. No dividends were paid in the period. As at 30 June 2013, the unaudited NAV was 112.2 pence per share, compared to anunaudited NAV of 108.5 pence per share as at 31 March 2013. The most notable contributor to performance came from Anpario(+30%),a leadingsupplier of natural high performance feed additives to the global agricultureand aquaculture markets. In the three months to 30 June 2013, Anpario's shareprice rose by 30%, whilst a final dividend of three pence per share wasapproved for payment to Anpario shareholders on 27 June 2013. Other noteworthy performances included; Accumuli(+23%), Avingtrans(+13%),Cohort(+12%),Mears Group (+12%) and Sagentia(+28%). A profit warning from IDOX (-24%), a leading supplier of document managementsoftware and services, provided the only meaningful disappointment in theperiod. Trading performance was held back by delays in completing expectedlarge deals in IDOX's Engineering Information Management division. Material Transactions There were two purchases and no disposals during the period:- Driver Group - a construction and engineering focused consultancy servicesgroup. The Company invested a further £410,000 in Driver Group, through a purchase ofshares in the secondary market. This investment is therefore non-qualifying forVCT purposes. Snacktime - the UK's third largest operator snack and drink vending machines. A follow-on investment in Snacktime completed on 5 April 2013. The Companyinvested a further £300,000 in this fundraising in the form of VCT qualifyingloan notes. With a new management team in place, a strengthened balance sheetand a significantly reduced cost base, Snacktime is now much better positionedto deliver a recovery of value for shareholders. Trading conditions remainchallenging however, and it should be noted that the longer term success ofSnacktime is now largely dependent upon the sales team's ability to generatemeaningful growth in new business. Top 10 Equity Holdings at 30 June 2013 Stock % of fund Abcam 13.8% Unicorn UK Smaller Companies Fund 8.7% Anpario 6.7% Mattioli Woods 4.4% Mears Group 4.2% Unicorn Mastertrust Fund 3.5% Cohort 3.1% Avingtrans 3.0% IDOX 3.0% Total 50.4% Share Buy-Backs/Issue of Equity During the period from 1 April 2013 to 30 June 2013, the Company bought back717,260 of its own Ordinary Shares at an average price of £0.90 per share. Inaddition, on 4th April 2013, 7,365,588 Ordinary Shares were repurchased underthe Enhanced Buyback Facility, the proceeds being applied to the subscriptionand allotment of 7,141,491 Ordinary Shares to participating shareholders at aprice of £1.119 per share. During the same period, a further 928,557 Ordinary shares were issued, atprices ranging between £1.144 and £1.26 per share under the Top Up Offer, whichcurrently remains open for subscription until 31 July 2013. Since 30 June 2013, 189,757 shares have been bought back at a price of £0.945per share and 44,997 Ordinary shares have been issued under the Top Up Offer ata price of £1.16. There were 56,836,873 Ordinary Shares in issue at the date of thisannouncement. Material Events There were no other material events during the period from 1 April 2013 to 30June 2013.
Date   Source Headline
1st Apr 202510:07 amRNSTotal Voting Rights
31st Mar 202511:15 amRNSOffer for Subscription - Update
18th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 202512:04 pmRNSOffer Update - Overallotment
11th Mar 20251:01 pmRNSDirector/PDMR Shareholding
11th Mar 202511:15 amRNSIssue of Equity under Offer
6th Mar 202511:14 amRNSNet Asset Value(s)
3rd Mar 202510:05 amRNSTotal Voting Rights
21st Feb 20257:00 amRNSDirector/PDMR Shareholding
21st Feb 20257:00 amRNSIssue of Equity
12th Feb 20251:27 pmRNSResult of AGM
4th Feb 20252:39 pmRNSNet Asset Value(s)
3rd Feb 202510:15 amRNSTotal Voting Rights
28th Jan 202512:14 pmRNSPublication of a Prospectus
17th Jan 20256:01 pmRNSTransaction in Own Shares
10th Jan 20253:31 pmRNSNet Asset Value(s)
2nd Jan 202512:51 pmRNSDirector Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
17th Dec 20244:18 pmRNSTransaction in Own Shares
9th Dec 20242:17 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSFinal Results
29th Nov 202411:59 amRNSDividend Declaration
27th Nov 20247:00 amRNSINTENTION TO LAUNCH AN OFFER
5th Nov 20243:05 pmRNSNet Asset Value(s)
18th Oct 202411:05 amRNSNet Asset Value(s)
2nd Oct 202410:30 amRNSDirectorate Change
1st Oct 20249:45 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20249:56 amRNSNet Asset Value(s)
2nd Sep 202410:02 amRNSTotal Voting Rights
16th Aug 20248:58 amRNSTransaction in Own Shares
13th Aug 20249:38 amRNSDirector/PDMR Shareholding
13th Aug 20249:16 amRNSIssue of Equity
6th Aug 20249:31 amRNSNet Asset Value(s)
8th Jul 20242:00 pmRNSNet Asset Value(s)
1st Jul 202410:12 amRNSTotal Voting Rights
20th Jun 20242:25 pmRNSTransaction in Own Shares
7th Jun 20247:00 amRNSNet Asset Value(s)
23rd May 20247:00 amRNSHalf-year Report
8th May 20249:47 amRNSNet Asset Value(s)
8th Apr 20241:46 pmRNSNet Asset Value(s)
2nd Apr 202410:46 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202411:59 amRNSTotal Voting Rights
11th Mar 202411:57 amRNSIssue of Equity
7th Mar 202411:34 amRNSNet Asset Value(s)
1st Mar 202410:54 amRNSTotal Voting Rights
15th Feb 20244:30 pmRNSOffer for Subscription Update
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.